Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

11.1%

2 terminated out of 18 trials

Success Rate

81.8%

-4.7% vs benchmark

Late-Stage Pipeline

17%

3 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed with results

Key Signals

1 with results82% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (1)
P 1 (3)
P 2 (3)
P 3 (1)
P 4 (2)

Trial Status

Completed9
Unknown5
Terminated2
Recruiting1
Withdrawn1

Trial Success Rate

81.8%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT04668872RecruitingPrimary

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

NCT05293041Phase 4CompletedPrimary

Argipressin's Influence on Blood Loss During Hepatic Resection

NCT04682665CompletedPrimary

Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases

NCT03370198Phase 1TerminatedPrimary

Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer

NCT02781935Completed

Diffusion-Weighted MRI for Liver Metastasis

NCT01464593Phase 2TerminatedPrimary

Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)

NCT03415126Phase 1Completed

A Study of ASN007 in Patients With Advanced Solid Tumors

NCT03310008Phase 1UnknownPrimary

Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases

NCT03175016Phase 2UnknownPrimary

Irinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal Cancer

NCT02363049Phase 3Unknown

Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer

NCT01730365Completed

Optical Detection of Malignancy During Percutaneous Interventions

NCT02631564UnknownPrimary

Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver Metastasis

NCT02557490Phase 4UnknownPrimary

Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases

NCT01891552CompletedPrimary

Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab

NCT01522209Not ApplicableCompletedPrimary

Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging

NCT02090816CompletedPrimary

Combined Liver and Right Lung Resection for Colorectal Metastases by Means of J-shaped Thoracophrenolaparotomy

NCT01540435Phase 2WithdrawnPrimary

Perioperative Treatment of Resectable Liver Metastases

NCT01526200CompletedPrimary

Contrast-Enhanced Intraoperative Ultrasound During Liver Surgery for Colorectal Cancer Liver Metastases

Showing all 18 trials

Research Network

Activity Timeline